JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
JOHNSON & JOHNSON
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026
$253.79−1.77 (-0.69%)
Close on Oct 19, 2026
- Market cap
- $619.27B
- P/E (TTM)
- 29.4
- Dividend yield
- 2.03%
Johnson & Johnson statistics
Financials through Jun 28, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Johnson & Johnson | Industry median |
|---|---|---|
| Market Cap | $611.61B | $166.30M |
| Enterprise Value | $639.89B | $88.19M |
| PE Ratio | 29.44 | 20.44 |
| PS Ratio | 6.25 | 3.65 |
| PB Ratio | 7.20 | 2.03 |
| P/FCF Ratio | 27.50 | 17.44 |
| P/OCF Ratio | 22.15 | 12.98 |
Enterprise value
| Measure | Johnson & Johnson | Industry median |
|---|---|---|
| EV / Sales | 6.53 | 2.51 |
| EV / EBITDA | 18.84 | 14.65 |
| EV / FCF | 28.77 | 20.86 |
Income (trailing twelve months)
| Measure | Johnson & Johnson | Industry median |
|---|---|---|
| Revenue | $97.93B | $58.34M |
| Gross Profit | $66.50B | $105.94M |
| Pretax Income | $25.20B | -$14.34M |
| Net Income | $21.04B | -$22.46M |
| EBITDA | $33.96B | -$16.91M |
| EPS (Diluted) | $8.62 | -$0.83 |
Margins
| Measure | Johnson & Johnson | Industry median |
|---|---|---|
| Gross Margin | 67.9% | 52.9% |
| Pretax Margin | 25.7% | -13.3% |
| Profit Margin | 21.5% | -40.2% |
| EBITDA Margin | 34.7% | -30.2% |
| FCF Margin | 22.7% | -9.27% |
Returns
| Measure | Johnson & Johnson | Industry median |
|---|---|---|
| Return on Equity (ROE) | 25.7% | -53.2% |
| Return on Assets (ROA) | 10.7% | -40.9% |
Growth
| Measure | Johnson & Johnson | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 8.06% | 5.96% |
| Net Income Growth (YoY) | -7.17% | -35.2% |
| EPS Growth (YoY) | -7.81% | -26.2% |
| FCF Growth (YoY) | 19.9% | 2.34% |
| Revenue Growth (3Y CAGR) | 5.60% | 2.25% |
| Revenue Growth (5Y CAGR) | 2.67% | 6.48% |
| EPS Growth (3Y CAGR) | 17.9% | -0.17% |
| EPS Growth (5Y CAGR) | 14.9% | 3.77% |
Balance sheet
| Measure | Johnson & Johnson | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $20.76B | $61.43M |
| Total Debt | $49.04B | $118.52M |
| Net Cash (Debt) | -$28.28B | $15.35M |
| Net Cash Per Share | -$11.73 | $0.66 |
| Equity (Book Value) | $84.97B | $49.09M |
| Book Value Per Share | $35.26 | $1.37 |
| Tangible Book Value | -$11.74B | $23.52M |
| Working Capital | $4.88B | $76.81M |
Financial position
| Measure | Johnson & Johnson | Industry median |
|---|---|---|
| Current Ratio | 1.09 | 3.34 |
| Quick Ratio | 0.73 | 2.44 |
| Debt / Equity | 0.58 | 0.52 |
| Debt / EBITDA | 1.44 | 3.44 |
| Debt / FCF | 2.20 | 4.89 |
| Net Debt / EBITDA | 0.83 | 2.36 |
Cash flow (trailing twelve months)
| Measure | Johnson & Johnson | Industry median |
|---|---|---|
| Operating Cash Flow | $27.61B | -$12.35M |
| Capital Expenditures | -$5.36B | -$1.08M |
| Free Cash Flow | $22.24B | -$20.22M |
| FCF Per Share | $9.23 | -$0.42 |
Efficiency
| Measure | Johnson & Johnson | Industry median |
|---|---|---|
| Asset Turnover | 0.50 | 0.39 |
| Inventory Turnover | 2.20 | 2.70 |
| Revenue Per Employee | $708.60K | $404.87K |
| Profits Per Employee | $152.22K | -$703.34K |
| Employee Count | 138,200 | 74 |
Dividends and yields
| Measure | Johnson & Johnson | Industry median |
|---|---|---|
| Earnings Yield | 3.44% | -23.3% |
| FCF Yield | 3.64% | -8.72% |
| Dividend Yield | 2.03% | 1.82% |
| Buyback Yield | 1.32% | -0.59% |
| Shareholder Yield | 3.35% | 0.00% |
| Dividend Per Share | $5.14 | $0.83 |
| Dividend Growth (YoY) | 4.68% | 2.37% |
| Years of Dividend Growth | 11 | 0 |
Shares
| Measure | Johnson & Johnson | Industry median |
|---|---|---|
| Shares Outstanding | 2,409,900,000 | 58,127,000 |
| Shares Change (YoY) | 0.59% | 10.9% |
| Float | 2,408,910,000 | 49,136,700 |
| Shares Held by Insiders | 0.04% | 11.6% |
| Shares Held by Institutions | 74.7% | 59.4% |
Taxes
| Measure | Johnson & Johnson | Industry median |
|---|---|---|
| Income Tax | $4.16B | $79.87K |
| Effective Tax Rate | 16.5% | 20.6% |
Scores
| Measure | Johnson & Johnson | Industry median |
|---|---|---|
| Graham Number | $82.70 | $18.73 |
| Graham Upside | -67.4% | -45.1% |
| Altman Z-Score | 4.87 | -0.22 |
| Piotroski F-Score | 4 | 4 |
| Beneish M-Score | -2.26 | -2.62 |
Calculated by StockData from Johnson & Johnson's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.